ObsEva (CHIX:OBSNZ) Days Sales Outstanding : 1.17 (As of Dec. 2022)

View and export this data going back to 2018. Start your Free Trial

What is ObsEva Days Sales Outstanding?

ObsEva's average Accounts Receivable for the three months ended in Dec. 2022 was CHF0.24 Mil. ObsEva's Revenue for the three months ended in Dec. 2022 was CHF18.29 Mil. Hence, ObsEva's Days Sales Outstanding for the three months ended in Dec. 2022 was 1.17.

The historical rank and industry rank for ObsEva's Days Sales Outstanding or its related term are showing as below:

CHIX:OBSNz's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 72.34
* Ranked among companies with meaningful Days Sales Outstanding only.

ObsEva's Days Sales Outstanding declined from Dec. 2021 (14.22) to Dec. 2022 (1.17).

ObsEva Days Sales Outstanding Historical Data

The historical data trend for ObsEva's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ObsEva Days Sales Outstanding Chart

ObsEva Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Sales Outstanding

Get a 7-Day Free Trial

56.88

34.13

ObsEva Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Days Sales Outstanding	Get a 7-Day Free Trial															14.22	-	-	-	1.17

Competitive Comparison of ObsEva's Days Sales Outstanding

For the Biotechnology subindustry, ObsEva's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ObsEva's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ObsEva's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where ObsEva's Days Sales Outstanding falls into.

ObsEva Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

ObsEva's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

	Days Sales Outstanding (A: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (3.186	+	0.235)	/	2 )	/	18.294	*	365
=	1.7105					/	18.294	*	365
=	34.13

ObsEva's Days Sales Outstanding for the quarter that ended in Dec. 2022 is calculated as:

	Days Sales Outstanding (Q: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2022 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (0	+	0.235)	/	1 )	/	18.294	*	365 / 4
=	0.235					/	18.294	*	365 / 4
=	1.17

ObsEva (CHIX:OBSNz) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

ObsEva Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of ObsEva's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

ObsEva (CHIX:OBSNZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ObsEva SA (CHIX:OBSNz) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Chemin des Aulx, 12, Plan-les-Ouates, Geneva, CHE, 1228

Website

https://www.obseva.com

ObsEva SA is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. The Company operates in one segment, which is the research and development of innovative women's reproductive, health, and pregnancy therapeutics. It includes advancing a development program for Nolasiban, an oral oxytocin receptor agonist, focused on improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization (IVF). Geographically, the majority is from Switzerland.

ObsEva (CHIX:OBSNZ) Headlines

No Headlines